Securities law firm Bleichmar Fonti & Auld LLP has launched an investigation into the board of RE/MAX Holdings, Inc. (NYSE: RMAX) over its pending merger with The Real Brokerage Inc., a deal valued at $13.80 per share.
"BFA Law is investigating whether the merger was executed at an unfairly low price and whether RE/MAX's insiders are receiving potentially unfair benefits," the firm stated in a press release on May 6, 2026.
The deal, announced on April 27, 2026, allows RE/MAX shareholders to elect either $13.80 in cash or 5.152 shares of the new entity, Real REMAX Group. The investigation highlights that the offer is below the company's 52-week high, raising questions about valuation. Other firms, including Brodsky & Smith, Halper Sadeh LLC, and Monteverde & Associates PC, have also announced similar probes.
The mounting legal scrutiny introduces significant risk to the merger's completion and could lead to shareholder lawsuits. The investigation focuses on potential breaches of fiduciary duties by the board and RE/MAX co-founder and chairman David Liniger.
The core of the investigations is whether the RE/MAX board conducted a fair process to maximize shareholder value. Brodsky & Smith noted that the deal consideration is below the 52-week high of the company's shares, a point of contention for those arguing the deal undervalues the company.
The merger agreement gives RE/MAX shareholders a choice, subject to proration, between cash and stock in the newly formed company. This structure is common in such transactions but is now being scrutinized for its fairness to all shareholders, particularly in light of the board's and insiders' roles.
The outcome of these investigations could potentially lead to a revised merger agreement with a higher price, or even the termination of the deal. Shareholders will be closely watching for any formal legal action or recommendations from the investigating law firms, which could serve as the next major catalyst for the stock.
This article is for informational purposes only and does not constitute investment advice.
